• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research on the payment system for preventing drug duplication and interaction under the separation of prescribing and dispensing

Research Project

Project/Area Number 13670355
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Public health/Health science
Research InstitutionThe Univesity of Tokyo

Principal Investigator

KOBAYASHI Yasuki  The University of Tokyo, Graduate School of Medicine, Professor, 大学院・医学系研究科, 教授 (70178341)

Co-Investigator(Kenkyū-buntansha) FUKUDA Takashi  The University of Tokyo, Graduate School of Pharmacy, Associate Professor, 大学院・薬学系研究科, 助教授 (40272421)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,900,000)
Fiscal Year 2002: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2001: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordsseparation of prescribing and dispensing / pharmaceuticals / drug interaction / drug duplication / health insurance / pharmacy / payment system
Research Abstract

We examined the present situation wherein pharmacies claimed the fees for preventing adverse duplications and/or interactions of prescription drugs, in order to consider the more relevant and effective payment system in Japan's health insurance systems. All of the pharmacies registered as "insurance pharmacy" by the Tokyo Metropolitan Government in April 1999 were surveyed in this regard. Out of 4,854 pharmacies, 1,506 (31.0%) responded. Of all of the prescriptions received by these pharmacies, the proportion of prescriptions claiming the fee was 0.0088%. This proportion was not significantly different between "Monzen Yakkyoku" pharmacies that received more than 70% of prescriptions from a particular medical institution, and the rest pharmacies. Other characteristics of pharmacies, such as number of pharmacists, size of the pharmacy, years of operation, being registered as a standard pharmacy by the Tokyo Metropolitan Government or not, were not significantly related to the proportion. We added an interview survey on some pharmacists, and found that the current payment system was inflexible in terms of claiming such fees. We also found, by another study, that more than 40% of the patients concurrently visited two medical institutions or more : Therefore, the issue of preventing adverse duplications and/or interactions of those drugs prescribed by different physicians/institutions is very important in terms of reforming the payment system.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] 林弘貴, 小林廉毅, 福田敬: "東京都の保険薬局における処方薬剤の重複投与・相互作用防止加算の算定状況"病院管理(日本病院管理学会雑誌). 40(1). 53-60 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kinoshita H, Kobayashi Y, Fukuda T: "Current charging practices for the prevention of drug duplication and interaction among pharmacies in Tokyo"Hospital Administration. 40. 53-60 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 木下弘貴, 小林廉毅, 福田敬: "東京都の保険薬局における処方薬剤の重複投与・相互作用防止加算の算定状況"病院管理(日本病院管理学会雑誌). 40(1). 53-60 (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi